PARD6G
Partitioning defective 6 homolog gamma
Also known as: PAR-6G, PAR6G_HUMAN, PAR6gamma
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BYG4
- Gene
- PARD6G
- Ensembl
- ENSG00000178184
- Chromosome
- 18
- Canonical length
- 376 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Predicted to be involved in centrosome cycle; establishment or maintenance of epithelial cell apical/basal polarity; and regulation of cellular localization. Predicted to be located in cytosol; plasma membrane; and tight junction. Predicted to be part of PAR polarity complex. Predicted to be active in apical plasma membrane; cell cortex; and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
376 residues, UniProt reviewed canonical sequence.
>Q9BYG4|PARD6G
1 MNRSFHKSQT LRFYDCSAVE VKSKFGAEFR RFSLDRHKPG KFEDFYKLVV HTHHISNSDV
61 TIGYADVHGD LLPINNDDNF CKAVSSANPL LRVFIQKREE AERGSLGAGS LCRRRRALGA
121 LRDEGPRRRA HLDIGLPRDF RPVSSIIDVD LVPETHRRVR LHRHGCEKPL GFYIRDGASV
181 RVTPHGLEKV PGIFISRMVP GGLAESTGLL AVNDEVLEVN GIEVAGKTLD QVTDMMIANS
241 HNLIVTVKPA NQRNNVVRGG RALGSSGPPS DGTAGFVGPP APRVLQNFHP DEAESDEDND
301 VVIEGTLEPA RPPQTPGAPA GSLSRVNGAG LAQRLQRDLA LDGGLQRLLS SLRADPRHSL
361 ALPPGGVEEH GPAVTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARD6G can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- skin: 36 nTPM
- esophagus: 17 nTPM
- thyroid gland: 17 nTPM
- vagina: 11 nTPM
- cervix: 9.5 nTPM
- ovary: 7.3 nTPM
Single-cell type
- podocytes: 334 nCPM
- lymphatic endothelial cells: 259 nCPM
- suprabasal keratinocytes: 115 nCPM
- basal keratinocytes: 90 nCPM
- esophageal suprabasal cells: 78 nCPM
- esophageal apical cells: 66 nCPM
Immune cell
- basophil: 0.5 nTPM
- memory CD8 T-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- hippocampal formation: 19 nTPM
- hypothalamus: 17 nTPM
- cerebral cortex: 17 nTPM
- choroid plexus: 14 nTPM
- medulla oblongata: 14 nTPM
- midbrain: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0.1
- gnomAD missense Z
- 1.84
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- centrosome cycle
- establishment or maintenance of cell polarity
- establishment or maintenance of epithelial cell apical/basal polarity
- regulation of cellular localization
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PARD6G in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARD6G as an antibody target. Whether an autoantibody or antibody against PARD6G could matter depends on whether native PARD6G is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARD6G is annotated at the cell surface, where native PARD6G is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PARD6G as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...